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Objective: Identify gene changes in articular cartilage of the medial tibial plateau (MTP) at 2, 4 and 8
weeks after destabilisation of the medial meniscus (DMM) in mice. Compare our data with previously
published datasets to ascertain dysregulated pathways and genes in osteoarthritis (OA).
Design: RNA was extracted from the ipsilateral and contralateral MTP cartilage, ampliﬁed, labelled and
hybridized on Illumina WGv2 microarrays. Results were conﬁrmed by real-time polymerase chain re-
action (PCR) for selected genes.
Results: Transcriptional analysis and network reconstruction revealed changes in extracellular matrix
and cytoskeletal genes induced by DMM. TGFb signalling pathway and complement and coagulation
cascade genes were regulated at 2 weeks. Fibronectin (Fn1) is a hub in a reconstructed network at 2
weeks. Regulated genes decrease over time. By 8 weeks ﬁbromodulin (Fmod) and tenascin N (Tnn) are the
only dysregulated genes present in the DMM operated knees. Comparison with human and rodent
published gene sets identiﬁed genes overlapping between our array and eight other studies.
Conclusions: Cartilage contributes a minute percentage to the RNA extracted from the whole joint
(<0.2%), yet is sensitive to changes in gene expression post-DMM. The post-DMM transcriptional
reprogramming wanes over time dissipating by 8 weeks. Common pathways between published gene
sets include focal adhesion, regulation of actin cytoskeleton and TGFb. Common genes include Jagged 1
(Jag1), Tetraspanin 2 (Tspan2), neuroblastoma, suppression of tumourigenicity 1 (Nbl1) and N-myc
downstream regulated gene 2 (Ndrg2). The concomitant genes and pathways we identify may warrant
further investigation as biomarkers or modulators of OA.
© 2014 The Authors. Published by Elsevier Ltd and Osteoarthritis Research Society International. This is
an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).to: A. Chanalaris, Arthritis
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Osteoarthritis (OA) is a polygenic, multifactorial disease of sy-
novial joints, characterised by articular cartilage degradation and
changes in other joint tissues1e3.
The molecular events occurring during disease initiation and
early progression are poorly understood. Initial large-scale gene
expression studies used osteoarthritic human cartilage from end-
stage disease4e7. These studies demonstrated changes in gene
expression in late stage OA but were unable to examine early mo-
lecular events as it is very difﬁcult to procure human cartilage from
different stages of disease and pair it with non-diseased age-
matched tissue. Animal models provide genetically controlled and
aged-matched tissue samples to allow the study of OA pathogen-
esis8. Broad molecular approaches are able to identify singleociety International. This is an open access article under the CC BY license (http://
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proteins that are dysregulated in disease9.
The destabilisation of the medial meniscus (DMM) surgical
model of OA is awidely used and validatedmodel of post-traumatic
OA10. We have used it to examine gene expression proﬁles shortly
after joint destabilisation. We found early gene expression changes
are highly mechanosensitive and largely attenuated by joint
immobilisation11. When analysing the whole joint tissue, immobi-
lised joints do not have increased expression of pathogenic pro-
teases such as Adamts5, Adamts4, Adamts1 and Mmp3, show
attenuated expression of inﬂammatory response genes like Ccl2,
Il1b and Il6 and are protected from disease. Similarly, joint immo-
bilisation led to decreased expression of those genes in the cartilage
at 6 h post-DMM. These results indicate the rapid response of
cartilage to DMM. We now extend these results showing gene
changes in this highly mechanosensitive tissue occurring beyond
6 h, over an 8-week course. We were interested in identifying
“phases” of disease progression that might provide novel targets
and new biomarkers for investigation in the human condition.
Methods
Animals and surgical model of OA
All procedures complied with the Animals (Scientiﬁc Pro-
cedures) Act 1986 and with guidelines of the local ethics commit-
tee. C57BL/6J male mice were purchased from Charles Rivers
(Margate, UK). Mice were housed 4e5 per standard individually
ventilated cages and maintained under 12-h light/12-h dark con-
ditions at an ambient temperature of 21C. Animals were fed a
certiﬁed mouse diet (RM3; Special Dietary Systems) and water ad
libitum. In total 187 animals were used in this study
(Supplementary Fig. 1).
DMM surgery was performed on 10-week-old mice during
daylight hours following the protocol described previously in
Ref. 11. The right knee (ipsilateral) was operated and the left
(contralateral) remained unoperated, acting as a control. For
microarray, three groups of eight mice were operated on per time
point (Fig.1). For histological analysis,10micewere operated onper
time point. For PCR, an extra three groups of ﬁve mice were oper-
ated on for each time point. An additional 15 mice were used to
quantify the amount of RNA extractable from each joint tissue.
Eleven of these mice were whole joint extractions and the other
four were micro-dissected. No pooling was performed for meniscus
or subchondral bone samples. Where pooling was performed, the
experimental unit was regarded as one (Supplementary Fig. 1).
Histological analysis
Knee joints from operated and contralateral limbs were
dissected and processed for histological analysis at 2, 4, 8 and 12
weeks. Two blinded independent observers scored the cartilage
morphology, as described previously in Ref. 11.
RNA extraction and whole genome expression analysis (WGA)
Micro-dissection of joint tissues was performed as previously
described in Ref. 11 at 2, 4 and 8 weeks following DMM surgery.
Detailed protocol is provided in the supplementary ﬁle. RNA
extraction, ampliﬁcation, cDNA labelling, hybridisations on an
Illumina Mouse WG-6 v2.0 Expression BeadChip (Illumina),
microarray processing, data analysis and construction of regulatory
pathways was performed as described in the Supplementary File.
Data are deposited in NCBI's Gene Expression Omnibus12 with GEOSeries accession number GSE53857 (http://www.ncbi.nlm.nih.gov/
geo/query/acc.cgi?acc¼GSE53857).Comparison of previously published microarray datasets
We compared our 2-week dataset with other arrays owing to
the size of our dataset and availability of other mouse arrays at this
time point. We selected previously published datasets fulﬁlling the
following criteria:
a. They were from pure knee cartilage RNA5e7,13e16, or enriched for
cartilage17;
b. They were of mouse14,17, rat13,15 or human origin5e7,16;
c. The rodent sets were from models of surgical induced knee
instability; and
d. Where possible we preferred the 2-week time point for
comparison14,17.
We used the gene-lists corresponding to the signiﬁcantly dys-
regulated probes of each study. Additionally, we compared the
overlap between our array and a gene-set speciﬁc for
inﬂammatory-related genes18. Details are found in the
Supplementary File. The Venn diagrams were constructed using
Venny19. Hypergeometric distribution probability mass function
(p.m.f.) calculations of overlaps observed between two sets were
done in R.Real-time (RT)-PCR
RT-PCR was performed using RNA from biological replicates at
each time-point as described before in Ref.11. The list of assays used
is available upon request.Results
Determining the relative abundance of articular cartilage RNA in the
whole joint
We established a method to isolate RNA from distinct tissues
within the mouse knee joint11. The tibial epiphysis contributes
almost half of the whole joint RNA (44% ± 20%), with lesser con-
tributions from meniscus (2.4% ± 1.5%) and cartilage
(0.174% ± 0.082%) [Fig. 1(A)]. Although the articular cartilage con-
tributes a small percentage of total joint RNA, it is clearly implicated
in early OA. Gene expression changes localised to this tissue may be
lost when taken with the whole joint tissue. The RNA isolation
technique resulted in 9 ± 4.3 ng RNA/joint from the pooled medial
tibial plateau (MTP) with a RIN of 8.4 ± 0.4 [Fig. 1(B)].
We extended our original observations by performing a micro-
array analysis of genes regulated speciﬁcally in the MTP cartilage
beyond 2 weeks.Histological cartilage degradation in operated joints relative to
controls
Operated joints showed progressive increase in pathological
changes over the 12-week time course [Fig. 1(C) and (D)]. Within
the operated joints, histological scores were consistently higher in
the medial compartment compared to the lateral compartment
[Fig. 1(D)]. No signiﬁcant pathological changes were detected in the
contralateral knees and there was no difference between the
medial and lateral compartment of the contralateral knees at any
time point.
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evolution following surgery
Pairwise comparisons of DMM-operated and contralateral MTP
cartilage were performed at 2, 4 and 8 weeks (Supplementary
Table S1). The number of regulated genes decreased with time
following surgery (Supplementary Table S2).
At 2 weeks, 1224 genes (1425 probes) were differentially
expressed [Fig. 2(A); Supplementary Table S3]. Keratocan (Kera)
was the most signiﬁcantly up-regulated gene, others included
Mmp3, Mmp2 along with a further 14 matrix metalloproteinases
(MMPs). Fibromodulin (Fmod) was one of a number of small
leucine-rich repeat proteins (SLRPs) up-regulated. Myh4 was the
most down-regulated gene, along with other contractile elements
and many genes from the serpin family [Fig. 2(A)].
At 4 weeks, 76 genes (90 probes) were differentially expressed
[Fig. 2(B), Supplementary Table S3] (20 genes were unique for week
4). Genes up-regulated at 2 weeks that were also up at 4 weeks
included Mmp3, Thrombospondin 3 (Thbs3), Tenascin N/W (Tnn),
Tenascin C (Tnc) and Fmod. Similarly to 2 weeks, many genes for
contractile elements were down-regulated. At 8 weeks, only Tnn
and Fmod were up-regulated (Supplementary Table S3); no genes
were down-regulated. Pairwise comparisons of control joints at 2, 4
and 8 weeks showed no difference in gene expression.
Network analysis was performed using STRING and EGAN. Each
node represents a protein and the edges their regulatory relation-
ships. Multi-edged nodes are described as hubs. At 2 weeks, 424
edges were observed between 233 nodes (Fig. 3). The interactions
revealed a number of hubs at the 2-week time point. Fibronectin
(Fn1) was the node with the highest number of edges, thus placing
it at the centre of the biggest network. Next was a cluster of col-
lagens with at least 10 edges each. Other nodes with at least 10
edges were the troponins, clusterin, decorin, syndecans 1 and 4 (Sdc
1 and 4), integrin b1 (Itgb1), perlecan (Hspg2), transforming growth
factor b2 (Tgfb2) and glypican 1 (Gpc1). At 4 weeks, 32 edges were
observed between 20 nodes (Fig. 3). The main network was clus-
tered around troponin T3 (Tnnt3); four sub-networks had a single
edge each.
Functional annotation clustering (FAC) analysis
To gain further insight into the biological signiﬁcance of the
gene expression changes KEGG pathway analysis (Supplementary
Table S4) and FAC was performed (Supplementary Tables S5eS7).
At 2-weeks, enriched KEGG pathways included ECM-receptor
interaction (P < 0.0001) and focal adhesion (P < 0.0001), which
contained collagens, tenascins, integrins and thrombospondins.
The pathways for hypertrophic cardiomyopathy (P ¼ 0.005), TGF-b
signalling (P ¼ 0.006), and dilated cardiomyopathy (P ¼ 0.008)
contained genes for integrins, IGF-1 and TGF-b2 and -b3. Comple-
ment and coagulation cascades (P < 0.0001) and regulation of actinFig. 1. Quantity and quality of RNA isolated from dissected knee tissues and histological sco
(n ¼ 22; 11 animals, 10e14 weeks of age) and from cartilage (n ¼ 20 each point is a pool of at
used for the meniscus and bone RNA isolation), meniscus (n ¼ 20) and tibial epiphysis with
fromMTP cartilage (n ¼ 29; each point is a pool of 4e8 MTPs, we used 102 mice in total rangi
72 used for the microarray). C: Histological assessment of coronal knee sections at 2, 4, 8 and
degradation of the unoperated (CL, blue boxes) and operated knees (IL, red boxes). For each
the ﬁrst to the ninety-ninth percentile of the scores with the median represented by the ho
(D'Agostino and Pearson omnibus normality test, P > 0.07). (*: P < 0.05, **: P < 0.01, ***: P <
the P values are multiplicity adjusted). D: Histological assessment of coronal knee sections a
of cartilage degradation of the unoperated (CL, blue boxes) and operated knees (IL, red boxe
mice were used (30 in total) (n ¼ 10). The whiskers cover the breadth of the ﬁrst to the nine
the box. The data were transformed by taking the square root of the values prior to the sta
distribution (D'Agostino and Pearson omnibus normality test, P > 0.07. (*: P < 0.05, **: P < 0.0
are multiplicity adjusted).cytoskeleton (P ¼ 0.002) were particularly enriched in down-
regulated genes. O-glycan and heparan sulphate biosynthesis
pathways (P ¼ 0.01 and P ¼ 0.04, respectively), and galactose
metabolism (P ¼ 0.04) are present. FAC analysis (Supplementary
Table S5) conﬁrmed the signiﬁcant presence of metal-
loproteinases (clusters 1, 6 and 9), collagens and thrombospondins
(cluster 2). Down-regulated genes (Supplementary Table S6)
showed involvement in cytoskeletal organisation (clusters 1, 2, and
4) and apoptosis (clusters 3 and 9).
At 4 weeks, KEGG analysis showed enrichment for ECM-
receptor interaction (P < 0.0001) and focal adhesion (P < 0.0001)
(Supplementary Table S4). In common with the 2-week time point
cytoskeletal elements were down-regulated. The KEGG pathway
for hypertrophic cardiomyopathy was enriched (P ¼ 0.022); it
contained the genes Actc1, Prkaa2 and Ttn. These genes did not
feature at 2 weeks. FAC conﬁrmed the dominance of cytoskeletal
elements (Supplementary Table S7).
RT-PCR veriﬁcation of gene expression changes
We selected four genes to evaluate based on those that were
signiﬁcantly changed at all time points (Fmod and Tnn) or are of
known importance in OA (Mmp3); ﬁnally Tnc was selected as it is a
homologue of Tnn andwas not signiﬁcantly regulated at 8weeks.We
evaluated cartilage from the medial and lateral plateaus of the
operated and contralateral joints at 2, 4 and 8 weeks following sur-
gery (Fig. 4). Gene expression in the lateral plateaus from the oper-
ated and contralateral joints was also evaluated by RT-PCR (Fig. 4).
Fmod, Tnn and Mmp3 (except 4 weeks) were up-regulated in the
medial plateau of the DMM joints compared with the lateral plateau
and contralateral joint, suggesting very localised response to injury.
Comparison of our dataset with previously published microarrays
As our study did not include any sham-operated controls, we
compared our 2-week dataset with previously reported datasets
from studies on mice 2 weeks post-DMM [Fig. 5(A)]. We observed
an overlap of 86 genes with the 2-week Bateman dataset
(P < 0.0001) and the same number of genes with the Loeser dataset
(P < 0.0001). There were 33 genes in common between the Bate-
man and Loeser studies (P < 0.0001). We also identiﬁed 11 genes in
common between the three datasets [Fig. 5(A) insert]. These
include Jag1, a ligand for Notch receptor. By comparing the KEGG
pathways enriched in each dataset [Fig. 5(B)], we show common
pathways (focal adhesion, regulation of actin cytoskeleton and TGF-
b signalling) in three out of the four microarrays, all studies using
pure cartilage.We also compared our dataset and eight other arrays
with a list constructed by genes involved in the inﬂammation
process18 (Fig. 5). We observed 72 genes at 2 weeks (P ¼ 0.03)
involved with inﬂammation [Fig. 5(C) and (D)] and 4 genes at 4
weeks (P ¼ 0.2) [Fig. 5(B)].res for cartilage degradation post-DMM. A: Amount of RNA isolated from a whole joint
least two joints; 30 mice in total, 10e14 years of age; the same group of 30 animals was
the cartilage removed (Bone) (n ¼ 20). B: Amount per joint and quality of RNA isolated
ng from 10 to 18 weeks old. This group includes the 30 animals used on panel A and the
12 weeks post-DMM. Boxes represent the summed histopathological score of cartilage
time point 10 mice were used (30 in total) (n ¼ 10). The whiskers cover the breadth of
rizontal line in the box. The values for all groups approximate a Gaussian distribution
0.001, ****: P < 0.0001 two way analysis of variance (ANOVA), Bonferroni post-hoc test,
t 2, 4, 8 and 12 weeks post-DMM. Boxes represent the summed histopathological score
s) on the medial (solid boxes) and lateral (checked boxes) side. For each time point 10
ty-ninth percentile of the scores with the median represented by the horizontal line in
tistical testing. After transformation the values for all groups approximate a Gaussian
1, ***: P < 0.001, ****: P < 0.0001 two way ANOVA, Bonferroni post-hoc test, the P values
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Fig. 3. Network representation of the proteineprotein interactions between genes that were signiﬁcantly regulated at 2 (right panel) and 4 weeks (left panel). Only genes with at
least one interacting partner are represented. Nodes are coloured according to the fold change in gene expression over the contralateral limbs. Green represents down-regulated
components and red represents up-regulated genes. The gradient bar shows the change in colour according to the fold change. The size of the node represents the signiﬁcance of the
observed change (adjusted P value for pairwise comparisons) with smaller nodes closer to 0.05 and increasing size towards an adjusted P value of 0. The dotted blue circles highlight
group of nodes in the 2 week network that has at least one connected member in the 4 week network. The titles of the circles, represent the functional group of the circled nodes
(MMPs: matrix metalloproteinases, SLRPs: small leucine repeat proteins).
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identify genes deregulated in OA regardless of species, time and
method of induction. At 2 weeks, 344 (28% of the regulated genes)
were represented in at least one other microarray. There were no
genes common to all arrays. The predicted overlap between our array
and ﬁve or more arrays is 0.74 genes, from an initial pool of 10,000
elements after 10,000 simulations. However, we observed 22 genes
overlapping in ﬁve ormore arrays. GO slim analysis for the biological
function of these 22 genes reveals that 50% of themare involvedwith
cell adhesion and 54.5% of them in developmental processes (Fig. 6).Discussion
This study provides new insights into the localisation and
temporal progression of gene expression. We used a novel micro-
dissection technique allowing us to examine the MTP cartilage in
isolation at a variety of time points post-disease induction. For the
ﬁrst time we demonstrate differential expression patterns in the
medial vs the lateral tibial plateau. We identiﬁed a new molecule
persistently up-regulated at every time point (Tnn, tenascin N) andFig. 2. Differentially expressed genes in the operated medial tibial cartilage at 2 (A) and 4
detected in our array was plotted against the base 2 logarithm of the P value that was adjus
than 0.35 are presented at 2 weeks, where the dotted vertical line represents the boundaries
greater than 1.5 and less than 0.5 are represented.modelled the evolution of gene changes as a network of potential
proteineprotein interactions, identifying Fn1 as a central node at 2
weeks post-DMM. Finally, we presented an analysis showing
commonality of disease-related genes across nine related studies
irrespective of time, species and nature of OA induction. The study
also provides important conﬁrmatory evidence for a marked
reduction in differential gene expression at 8 weeks, which was a
surprising observation when recently reported by others17.
We studied the MTP cartilage as it degrades ﬁrst17,20 mirroring
the focal nature of cartilage lesions in human OA. Recent tran-
scriptomic studies have used rat13,15 and mouse models11,14,17,21,22
to assess gene regulation in OA. Several studies focused on chon-
drocyte gene expression either by manual micro-dissection of
cartilage13,15,21, or by laser capture14. These studies, along with our
previous work11 have identiﬁed signiﬁcant alterations in cartilage
homeostasis in early disease. The signiﬁcant overlap between pure
cartilage andwhole knee studies [Fig. 5(A)] highlights that cartilage
contributes a signiﬁcant proportion of the transcriptional changes
although it constitutes a very small percentage of the joint. This
study conﬁrms the anatomical localisation of gene expression to(B) weeks. The base 2 logarithm of the fold change for each gene that was conﬁdently
ted for multiplicity. The names of the genes with a fold change greater than 2.8 or less
for those fold changes. At 4 weeks the signiﬁcantly regulated genes with a fold change
Fig. 4. Quantitative RT-PCR demonstrates that the selected genes are regulated mainly on the MTP cartilage. LL: contralateral lateral, LM: contralateral medial, RL: ipsilateral lateral,
RM: ipsilateral medial. [n ¼ 3 and each point is a pool of ﬁve cartilage compartments; therefore 45 mice were used; data from 30 of these mice were used for the data on Fig. 1(A)
and (B) as well.]
M.D. Gardiner et al. / Osteoarthritis and Cartilage 23 (2015) 616e628622areas of cartilage degeneration and strengthens the case for inter-
rogating individual tissues of the joint.
A new ﬁnding was the persistent regulation of Tnn and Fmod at
every time point. TNN is found in the kidney and sites of bone andFig. 5. Gene and pathway overlap among our data and previously published microarrays i
signiﬁcantly regulated genes 2 weeks post-DMM (Blue: our results, Yellow: on RNA from
201314, Green: dataset from whole medial knee joint over SHAM operated mice from Loeser
three studies. B. Venn diagram depicting the overlap for KEGG pathways that were signiﬁcan
Bateman et al., 201314 as in A; Green: Loeser et al., 201317, as in A; Red: genes regulated in th
and partial medial meniscectomy over SHAM, Appleton et al., 200713.) Insets contain the list
association between gene-sets of signiﬁcantly regulated genes following surgically-induced
Bateman et al., 201314 as in A; Green: Appleton et al., 200713, as in B; Red: a set of inﬂamm
distribution p.m.f. for the associations of the nine arrays study here with the inﬂammatory gsmooth muscle development, including periosteum23. During
development, it contributes to mineralisation of the mouse cavarial
bones24. In contrast to Tnc, Tnn is down-regulated during differ-
entiation ofMC3T3-E1mesenchymal cell (MSC) line to bone25. Bothn mice undergone DMM. A. Venn diagram showing the overlap between gene-sets of
microdissected tibial plateau cartilage over SHAM operated mice from Bateman et al.,
et al., 201317). The inset contains the list of 11 genes that are differentially regulates all
tly enriched in four different studies in rodents. (Blue: Current study, 2 weeks; Yellow:
e rat femoral and tibial cartilage at 4 weeks post-anterior cruciate ligament transection
of the overlapping KEGG pathways for each comparison. C. Venn diagram showing the
OA in rodents and inﬂammation related genes. (Blue: Current study, 2 weeks; Yellow:
ation-related genes identiﬁed bioinformatically, Loza et al., 200718.) D. Hypergeometric
ene-set from Loza et al., 2007, as in C. Dotted lines depict probabilities of 0.01 and 0.05.
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Fig. 6. Comparison of amount of overlap between our study and previously published microarrays on cartilage from surgically induced OA in rodents and in OA human samples.
Frequency histogram (squares) of the genes regulated in the current study and in eight previously published microarrays6,7,13e17,43. The expected number of genes was calculated by
running a customised simulation of overlap between random samplings equal to the size of the compared array sets, without substitution and starting either from a sampling group
of 10,000 (circles), or 15,000 (triangles) genes in MATLAB. The top table contains the genes with the highest frequency of occurrence among the gene sets studied. The bottom table
contains the information on Biological Process gene ontology terms that were signiﬁcantly overrepresented among the genes with the highest frequency of occurrence.
M.D. Gardiner et al. / Osteoarthritis and Cartilage 23 (2015) 616e628 625tenascins are regulated by BMP2 and the Wnt pathway25. Both
tenascins and Fmod were strongly associated with chondrocyte
dedifferentiation26. The up-regulation of Fmod and Tnn could be
part of cartilage dedifferentiation in response to trauma, possibly as
an adaptation or repair attempt. This could also explain the tran-
scriptional changes we observed involving ECM remodelling,
changes in actin cytoskeleton, attenuation of the muscle pheno-
type, deregulation of the TGF-b pathway and up-regulation of
ﬁbromodulin and tenascins C and N. The 22 genes identiﬁed in our
microarray comparison further support this hypothesis as most are
involved in development and cell adhesion (Fig. 6).
Fibromodulin is thought to regulate collagen ﬁbril cross-
linking, perhaps driving it towards a denser network27,28. The
rapid accumulation of ﬁbromodulin has been described in carti-
lage of late stage canine OA28. Both mRNA and protein for
ﬁbromodulin, biglycan and decorin are increased in human knee
OA29. Fibromodulin, along with decorin and biglycan, bind to
active TGF-b and release it when degraded. TGF-b1 also up-
regulates ﬁbromodulin expression, perhaps as a negative feed-
back loop to increase sequestration30. Interestingly, recombinant
ﬁbromodulin alone can reprogram human ﬁbroblasts into mul-
tipotent cells31.
The TGF-b pathway was enriched in this study. At 2 weeks,
Tgfb2, Tgfb3, Ltpb1 (latent TGF-b binding protein 1) and Ltpb4 were
up-regulated but the receptors Tgfbr1 and Tgfbr3 were down-
regulated. Ltbp1 is involved in sequestration and activation of
TGF-b32. Gremlin 1 (Grem1), an antagonist of TGF-b and the Wnt
signalling pathway, was strongly down-regulated at 2 weeks.
Gremlin 1 and FRP were identiﬁed as ‘natural breaks’ on hyper-
trophic differentiation of articular chondrocytes33. TGF-b is known
to play a key role in osteophyte formation34 and two recent papers
present conﬂicting roles of TGF-b in cartilage degradation35,36.
Transgenic expression of TGF-b1 in murine osteoblasts induces OA
and inhibition of TGF-b1 by antibodies or by deletion of TGF-b type
II receptor, in nestin-positive MSCs, leads to less pronounced
cartilage degradation after surgery-induced OA35. Conversely,
deletion of TGF-b type II receptor in articular chondrocytes, induced
progressive OA36. TGF-b action within a knee joint appears to be
tissue dependent. TGF-b activity in the subchondral bone or in bone
marrow MSCs might promote OA through bone remodelling but in
the cartilage TGF-b is required for the maintenance of the chon-
drocyte phenotype. Levels outside the normal physiological range
may promote cartilage degeneration.
Contractile elements formed another enriched group in this
study. They were down regulated at both 2 and 4 weeks. Previous
studies showed altered expression of contractile genes21,22. In STR/
Ort mice knee cartilage they were higher in aged STR/Ort mice
compared to control mice of the same age21 and these genes were
down-regulated as the cartilage aged. A previous study identiﬁed
Myod1, Actc1, Actn2, Tnnc and Tnnt1 to be down-regulated over the
time of differentiation to a hypertrophic phenotype37. Similarly to
our study, genes associated with a muscle phenotype were down-
regulated in the DMM-operated knees in the rat13. When
comparing post-traumatic OA in old and young mice22, the con-
tractile genes were down in the young cohort and up in the old one.
They were also lower in the old sham-operated knees compared to
the young sham-operated. The regulation of those genes appears to
be dependent on the age of the tissue at injury.
Dio2, a gene linked with susceptibility to OA in humans was
induced at 2 weeks38. Dio2 protein was expressed at higher levels
in OA cartilage39. Interestingly, Pthr1, a receptor for the OA sus-
ceptibility gene Pthlhwas also induced at 2 weeks40. Increased Dio2
expression, by altered methylation of the risk allele, leads to lower
ECM deposition and induction of catabolic and mineralisation
markers41, providing an explanation for epigenetic effects on therisk allele, leading to induction of the Dio2 gene and an OA-like
phenotype41.
A marked decrease in gene expression at 8 weeks following
DMM surgery, with a subsequent increase at 16 weeks, was
observed in the whole knee17. Our study supports this observation
at 8 weeks. One might argue that the chondrocytes reach a new
state that is almost indistinguishable at the gene level from the
chondrocytes on the unoperated limb, apart from the persistence of
Fmod and Tnn. This might reﬂect a transient adaptation to the
altered biomechanical environment, which cannot be maintained
in the presence of continuous biomechanical changes. Therefore
possibly reﬂecting a point of no return if the abnormal biome-
chanical status persists. If true, it might be the last point of thera-
peutic intervention and requires further investigation.
We reconstructed interactions between regulated genes at 2 and
4 weeks. This revealed pathogenic elements including the potential
interplay between ECM components and growth factors, the com-
plement and coagulation systems, changes in focal adhesion and
integrins and changes to the cytoskeleton. At 2 weeks, ﬁbronectin
(Fn1) was identiﬁed at the centre of the main subnetwork,
consistent with previous studies5,6,14,21.
Olex et al.42 recently identiﬁed signalling and metabolic path-
ways post-DMM inmice by reconstructing networks based on their
previous microarray data17. Among the affected pathways are ECM-
receptor interaction, focal adhesion and the TGFb signalling
pathway, in agreement with our results. They also show involve-
ment of the Wnt and hedgehog signalling pathways and riboﬂavin
metabolism. Although we did not map the latter pathways, many of
their constituent genes are dysregulated in our study. These include
Sfrp2 and 4, Fzd6 and 10, Wif1, Wisp1 Wisp2, Gli1, Ptch1 and Enpp2
and 3.
We compared our results with a recent microarray study of the
tibial articular cartilage after DMM14. Eighty-six regulated genes
overlapped at the 2-week time point [Fig. 5(A)]. Enriched pathways
included the TGFb signalling pathway (Dcn, Thbs3, Bmp6). Fibro-
nectin, the key hub in our 2-week network, was also present.
Comparison of commonly regulated genes among other studies,
using the DMM model in the mouse17 or rat13, revealed TGFb,
regulation of the actin cytoskeleton and focal adhesion as the three
commonly dysregulated pathways [Fig. 5(B)]. Previously a panel of
20 commonly regulated genes between rat and human OA was
identiﬁed15. The same panel of genes showed 16 of those genes
dysregulated in the mouse cartilage at any one time point14. We
show agreement for 12 of the 20 genes (Aqp1, Col3a1, Col4a1,
Col6a2, Lum,Mmp3, Nbl1, Ndrg2, Pcolce, Timp1, Timp3, Tubb2b). This
motivated us to identify the overlap between our study and other
microarrays in human samples. We have identiﬁed 194 genes in
commonwith16, 88 genes with7, 33 with43 and 19 with6 (P < 0.0001
for all those comparisons). Three genes were up-regulated in all the
human microarrays and ours (Col15a1, Fn1 and Timp3). KEGG
pathways common to these arrays include ECM and focal adhesion;
TGFb signalling is common to two datasets [Figs. 5 and 6]. Some
notable genes with high coverage between arrays, like Ltbp2 and
Col5a1 (in 7/9 examined), Inhba (in 6/9), Serpine1 (5/9) and Adamts5
(4/9) were not detected in our array. However, we are able to detect
either homologues of those genes (Ltbp1 and 4, Col5a2 and other
Serpins) or changes in their pathways (TGFb for Ltbp2 and Inhba). It
is difﬁcult to attribute the undetectability to either a methodolog-
ical or biological bias. We expect that both sources of variation
contribute equally. However, for Adamts5 we believe this to be
mainly due to biological variation, given the poor repeatability
among the various studies (4/9) and that we can only detect it very
early after DMM (6-h) only by qPCR. Generally, the different
microarray platform chosen, in combination with different ampli-
ﬁcation and labelling methods is probably the key factors behind
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meta-analysis of microarray studies and so far no satisfactory way
to tackle this problem exists44e46. A way to address this problem is
to compare pathways that are dysregulated, rather than actual
genes.
A limitation of this study is the use of contralateral knees rather
than sham-operated controls. Although this reduced our animal
use by 50%, it created two main issues. First, changes in the joint
might be related to surgery itself, increasing the likelihood of false
positives. Second, there may be changes occurring in the contra-
lateral joint as a result of ipsilateral disease, perhaps driven by
possible systemic factors or altered loading owing to the operated
ipsilateral joint. Importantly, there was no statistical difference in
histological scores or gene expression in the contralateral joints
over time. Moreover, there is signiﬁcant overlap between genes
regulated in our study and those of other studies that included a
sham control. Our histological observations and our previous work
investigating pain following DMM show neutrophil inﬁltration in
the joint cavity and synovitis is present post-operatively in the
joints of both sham and DMM animals; this is normally acute and
dissipates after the ﬁrst week47. Comparing our dataset to a group
of inﬂammation related genes18, shows that although there is a
signiﬁcant overlap between our 2-week dataset and the inﬂam-
matory one, the p.m.f. of this overlap is a lot higher than those
observed for the datasets that originated against a sham control or
healthy human cartilage samples [Fig. 5(D)]. In other words, carti-
lage produces inﬂammatory-related genes that are involved in the
disease process. The number of those inﬂammatory genes appears
to diminish at 4 weeks in the cartilage, as the p.m.f. increased to 0.2
indicating that such an overlap could be due to chance [Fig. 5(D)].
The examined transcriptome data indicate changes to the
transcriptional wiring that affect:
1) ECM organisation
2) cell adhesion
3) TGFb (and other signalling pathways like Notch, FGF and IGF),
and
4) chondrocyte differentiation.
However, we are still unaware how these events are related to
each other and how the altered mechanical status and the ageing
process affect these components.
This study reinforces the transcriptomic approach to under-
standing disease pathogenesis and the relative importance of
chondrocyte-driven changes in gene expression.
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